Abstract:OBJECTIVE:To construct a prokaryotic expression system to serially express Alloferon-1 and to determine the anti-tumor activity of its products in vitro. METHODS:An artificial fusion gene containing 6 x His-EK-8 x Alloferon-1-EK-6 x His sequences was constructed by linking primer PCR. By using routine molecular biological methods, the artificial fusion gene was cloned and its prokaryotic expression system was then constructed. SDS-PAGE and BioRad Agarose Image Analysor was applied to measure the expression and output of the target recombinant products 8 x rAlloferon-1-EK. Ni-NTA affinity chromatography and EK digestion and Sephadex G-50 chromatography were performed to extract 8 x rAlloferon-1-EK and rAlloferon-1-EK, respectively. The proliferation of KB, SGC and HL-60 tumor cells was tested by using MTT method after treatment with directly synthesized Alloferon-1 (sAlloferon-1), Aloferon-1-EK (sAlloferon-1-EK) and rAlloferon-1-EK. RESULT:The target artificial fusion gene and its prokaryotic expression system pET42a-8 x rAlloferon-1-EK-E. coliBLDE3 with the expected sequences were obtained. Under inducement of IPTG, the prokaryotic expression system expressed the target serial recombinant protein 8 x rAlloferon-1-EK and its output was approximate 30 % of the total bacterial proteins. 8 x rAlloferon-1-EK and rAlloferon-1-EK were obtained through Ni-NTA and Sephadex G-50 columns. sAlloferon-1, sAlloferon-1-EK and rAlloferon-1ìrAlloferon-EK showed similar remarkable effects of inhibiting the growth and proliferation of KB, SGC and HL-60 cells in vitro within 25 approximately 100 microg/ml concentration range (P<0.01), and there were no significant differences in the inhibiting effects among the three agents (P>0.05). CONCLUSION:A prokaryotic expression system to serially express rAlloferon-1 has been successfully constructed. The product rAlloferon-1-EK has a similar anti-tumor activity compared to both the synthesized Alloferon-1 and Alloferon-1-EK in vitro.

[Expression of D-animo Acid Oxidase Gene in K562 Cells and the Cytotoxicity of D-alanine to the Cells].

Expression and Cytotoxicity of EGFP-labeled D-amino Acid Oxidase in HeLa Cells.

Construction and Expression of Recombinant Retroviral Vector Containing D-Amino Acid Oxidase cDNA

High-level soluble expression of the hemA gene from Rhodobacter capsulatus and comparative study of its enzymatic properties.

[Serial Recombinant Expression and Anti-Tumor Activity in Vitro of Antibiotic Peptide Alloferon-1].

Astilbic Acid Induced COLO 205 Cell Apoptosis by Regulating Bcl-2 and Bax Expression and Activating Caspase-3.

[Serial Recombinant Expression and Activity Against Tumor Cells in Vitro of Antibacterial Peptide Alloferon-1].

DAAO Mutant Sites among Different Mice Strains and Their Effects on Enzyme Activity

CLytA-DAAO, Free and Immobilized in Magnetic Nanoparticles, Induces Cell Death in Human Cancer Cells

Bcl-2 Antisense Oligodeoxynucleotide Enhances Araninosyl Cytosine-Induced Apoptosis of Primary Leukemia Cells

D-alanine suppressed osteoclastogenesis derived from bone marrow macrophages and downregulated ERK/p38 signalling pathways

The Expression of DAO in Gastric Cancer Cells and Gastric Mucosa Cells

Expression of Deoxycytidine Kinase and Cytidine Deaminase Mrna in Children with Acute Leukemia

Expression and Cytotoxicity of RFP-labeled Yeast Cytosine Deaminase in HeLa Cells

[Study on the Effect of Cell Proliferation and Anti-Oxidative Damage of Aldehyde Dehydrogenase-2 Gene Transfected into K562 Cells].

Gene Synthesis and Fusion Expression D-Aminoacylase Gene from Alcaligenes A-6

[Antiapoptotic Effect of the Leukemia Associated Gene MLAA-34 in HeLa Cells].

Enhanced anti-cancer efficacy of arginine deaminase expressed by tumor-seeking Salmonella Gallinarum

Delivery of amino acid oxidase via catalytic nanocapsules to enable effective tumor inhibition

A Novel Andrographolide Derivative AL-1 Exerts Its Cytotoxicity on K562 Cells Through a ROS-dependent Mechanism.